Number of oncology clinical trial starts 2000-2018 worldwide, by commercial sponsor

This statistic shows the number of oncology biomarker clinical trials started in the U.S. from 2000 to 2018, by commercial sponsor. During these years, Roche/Genentech sponsored the highest number of trials with 646 clinical trial starts, followed by Norvartis, who was involved in 600 clinical trial starts.

本统计数据显示了2000年至2018年间美国开展的临床肿瘤生物标志物临床试验数量，按商业赞助商分类。在这段时间内，罗氏/基因泰克赞助的临床试验数量最多，达到646项临床试验启动，紧随其后的是诺华公司，其参与了600项临床试验的启动。